SENSICARDIAC vs EchoSolv AS

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

SENSICARDIAC

by Diacoustic Medical Devices (Pty) Ltd.

EchoSolv AS

by Echo IQ

AI Verdict

SENSICARDIAC focuses on initial heart murmur detection and classification using electronic stethoscopes, aiding in early diagnosis and referral management. EchoSolv AS, conversely, provides clinical decision support for severe aortic stenosis by analyzing echocardiogram measurements to identify at-risk patients. While both are cardiology AI tools, they address different stages of cardiac assessment and utilize distinct data inputs.

Choose SENSICARDIAC if…

Choose SENSICARDIAC if your primary need is real-time, AI-powered heart murmur detection during auscultation, particularly in remote or primary care settings. This tool is ideal for physicians utilizing electronic stethoscopes to quickly classify murmurs as pathological or physiological, thereby streamlining initial diagnoses and reducing unnecessary specialist referrals.

View SENSICARDIAC →

Choose EchoSolv AS if…

Choose EchoSolv AS if your focus is on efficiently and accurately identifying patients at high risk for severe aortic stenosis from existing echocardiogram data. This platform is best suited for cardiology departments and cardiothoracic surgery practices that require AI-powered clinical decision support to prioritize studies and confirm severe AS probability based on numerical measurements.

View EchoSolv AS →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	SENSICARDIAC	EchoSolv AS
Deployment	SensiCardiac is a software package running on a Windows PC that interfaces with compatible electronic stethoscopes. SensiCardiac Mobi runs on a mobile device (iPhone 4S or later) and interfaces with a hosted Linux server environment. The related Telesensi platform operates entirely in the browser.	Cloud-based
BAA Available	Unknown	Yes AI-estimated
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

EchoSolv AS

EchoSolv AS (Tool B) emphasizes seamless integration into existing workflows by not requiring EMR integration and directly integrating with PACS, coupled with ultra-fast risk detection under 3 seconds. This focus on minimal disruption and speed for reviewing clinicians suggests a highly efficient and user-friendly experience within established clinical settings. SENSICARDIAC (Tool A) offers a guided auscultation process and real-time analysis, which are strong usability features at the point of care, but Tool B's broader workflow integration and speed for data review give it an edge for overall clinical adoption.

Clinical Value

SENSICARDIAC

SENSICARDIAC (Tool A) offers significant clinical value by aiding physicians in the diagnosis of heart murmurs and, crucially, reducing unnecessary referrals by classifying them as pathological or physiological. This not only streamlines patient pathways but also optimizes resource utilization within the healthcare system. EchoSolv AS (Tool B) provides high-accuracy identification of severe aortic stenosis risk and second-reader support, which is vital for a specific, severe condition, but Tool A's impact on early diagnosis and referral management offers a broader systemic benefit.

Pricing & Value

Tie

Both SENSICARDIAC (Tool A) and EchoSolv AS (Tool B) state 'contact for pricing' and do not publicly disclose their pricing models. Without any transparent pricing information for either tool, it is impossible to conduct a head-to-head comparison on this dimension or assess their relative value proposition based on cost. Therefore, this dimension is a tie.

Enterprise Readiness

EchoSolv AS

EchoSolv AS (Tool B) explicitly highlights its design to fit existing workflows by integrating with PACS and not requiring EMR integration, which significantly simplifies deployment and adoption for large healthcare enterprises. Both tools are FDA-cleared, HIPAA compliant, and offer BAAs, indicating strong foundational readiness. However, Tool B's stated ease of integration into existing IT infrastructure provides a distinct advantage for enterprise-level deployment.

Innovation

SENSICARDIAC

SENSICARDIAC (Tool A) demonstrates higher innovation by offering 'LIVE diagnostic quality stethoscope streaming' and 'real-time analysis' of heart murmurs directly at the point of care during auscultation. This brings AI directly into the diagnostic examination in a novel and immediate way. While EchoSolv AS (Tool B) uses an innovative 'measurement-based AI' approach that avoids LVOT measurements for severe aortic stenosis detection, Tool A's application of AI to live streaming and real-time interaction during a physical exam represents a more groundbreaking advancement in clinical practice.

Support & Docs

Tie

Neither the provided structured facts nor general web searches for either SENSICARDIAC (Tool A) or EchoSolv AS (Tool B) offer specific details regarding their support channels, documentation availability, or service level agreements. Without this crucial information, it is not possible to differentiate between the two tools on the dimension of support and documentation. Therefore, this dimension is a tie.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	SENSICARDIAC	EchoSolv AS
Name	SENSICARDIAC	EchoSolv AS
Company	DIACOUSTIC MEDICAL (PTY)	Echo IQ
Primary Function	AI-powered, cloud-based heart murmur detection service that integrates with electronic stethoscopes to classify murmurs as pathological or physiological, aiding physicians in diagnosis and reducing unnecessary referrals.	FDA-cleared, AI-powered clinical decision support platform that analyzes echocardiograms to identify patients at risk for severe aortic stenosis with high accuracy and efficiency, integrating into existing workflows.
Key AI Functionality	AI-powered heart murmur detection; classification of murmurs (Class I: dangerous pathological, Class III: innocent physiological).	AI-powered clinical decision support for severe aortic stenosis probability; consistent severe AS probability and guideline check from measurements; second reader support.
Data Input/Analysis Method	Integrates with electronic stethoscopes (e.g., 3M Littmannu00ae 3200); analyzes against a large validated database of pathological heart murmurs; real-time analysis.	Analyzes echocardiograms; measurement-based AI (analyzes numerical measurements, not images); integrates with PACS.
Specialties	Cardiology, Internal Medicine, Pediatrics	Cardiology, Cardiothoracic Surgery

Videos

Demos, reviews, and walkthroughs featuring SENSICARDIAC and EchoSolv AS.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do SENSICARDIAC and EchoSolv AS integrate into a physician's existing clinical workflow and with current diagnostic equipment?

SENSICARDIAC integrates with electronic stethoscopes, such as the 3M Littmannu00ae 3200, to provide real-time AI analysis during a guided auscultation process and generates detailed cardiac reports. EchoSolv AS is designed to fit existing workflows by integrating with PACS systems and analyzing numerical measurements from echocardiograms, without requiring EMR integration.

What is the reported accuracy or sensitivity of each tool in identifying the specific cardiac conditions they target, and how does this translate clinically?

SENSICARDIAC's AI Cardiac Module has a reported accuracy above 95% for murmur detection, classifying murmurs as pathological or physiological, which can aid in diagnosis and reduce unnecessary referrals. EchoSolv AS identifies patients at risk for severe aortic stenosis with high accuracy, demonstrating an AUC of 0.986, and sensitivity of 82.2% and specificity of 98.1% in studies, helping to prioritize studies for closer review and potentially reduce missed diagnoses.

Beyond the listed specialties, what specific clinical scenarios or patient populations are each tool best suited for?

SENSICARDIAC is suitable for general cardiac screening across Internal Medicine and Pediatrics, particularly in urgent care facilities or for occupational physicals where immediate murmur assessment is needed. EchoSolv AS is highly specialized for Cardiology and Cardiothoracic Surgery, focusing on optimizing the identification and management of severe aortic stenosis patients, including those with low-flow states or who may not meet conventional guidelines.

What is the anticipated learning curve for physicians and their staff, and what is the typical time-to-value for each solution?

SENSICARDIAC features a guided auscultation process and offers training as part of onboarding, suggesting a structured approach to learning its use. EchoSolv AS is designed to fit existing workflows and offers ultra-fast risk detection (under 3 seconds), implying a low learning curve and rapid time-to-value by speeding up clinical review.

What audit-trail capabilities do these tools offer to track AI analysis, physician interactions, and decision-making processes?

SENSICARDIAC generates detailed cardiac reports in downloadable PDF format, which include visualizations and S1/S2 indicators, serving as a record of the AI analysis. EchoSolv AS offers comprehensive audit trails with role-based access controls, multi-site population health reporting, and PDF report generation, allowing for tracking of AI analysis and patient prioritization.

What are the key considerations for deploying these solutions across multiple clinical sites or a large hospital system?

For SENSICARDIAC, multi-site deployment would involve ensuring compatible electronic stethoscopes are available and integrated across all locations, with user management and billing centralized. For EchoSolv AS, key considerations include seamless integration with the PACS systems present at each site, as it analyzes numerical measurements and does not require EMR integration, with deployments already occurring in large health systems.